Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

NCT02349906 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immunodeficiencies
Inborn Errors of Metabolism
Haemoglobinopathies
Bone Marrow Failure Syndromes

Interventions

DRUG: Treosulfan
DRUG: Busilvex

Sponsor

medac GmbH

Collaborators

[object Object]
[object Object]
[object Object]